RARS2

arginyl-tRNA synthetase 2, mitochondrial, the group of Aminoacyl tRNA synthetases, Class I

Basic information

Region (hg38): 6:87513459-87590028

Previous symbols: [ "RARSL" ]

Links

ENSG00000146282NCBI:57038OMIM:611524HGNC:21406Uniprot:Q5T160AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pontocerebellar hypoplasia type 6 (Definitive), mode of inheritance: AR
  • pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 6 (Supportive), mode of inheritance: AR
  • complex neurodevelopmental disorder (Limited), mode of inheritance: AD
  • pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
  • mitochondrial disease (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Pontocerebellar hypoplasia, type 6ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic17847012; 20635367; 22569581; 25809939

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RARS2 gene.

  • not provided (54 variants)
  • Pontocerebellar hypoplasia type 6 (11 variants)
  • Inborn genetic diseases (2 variants)
  • Pontoneocerebellar hypoplasia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RARS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
179
clinvar
1
clinvar
182
missense
1
clinvar
12
clinvar
106
clinvar
8
clinvar
4
clinvar
131
nonsense
23
clinvar
25
clinvar
48
start loss
5
clinvar
3
clinvar
8
frameshift
25
clinvar
48
clinvar
2
clinvar
75
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
8
clinvar
48
clinvar
56
splice region
1
1
10
48
4
64
non coding
2
clinvar
6
clinvar
220
clinvar
42
clinvar
270
Total 62 138 119 407 47

Highest pathogenic variant AF is 0.0000263

Variants in RARS2

This is a list of pathogenic ClinVar variants found in the RARS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-87514172-G-A Benign (Jun 26, 2018)1260098
6-87514298-C-T Benign (Jun 26, 2018)1294199
6-87514311-CA-C Benign (Aug 10, 2019)1291574
6-87514311-C-CA RARS2-related disorder Benign (Aug 21, 2019)1221069
6-87514311-C-CAA RARS2-related disorder Likely benign (Apr 29, 2020)3043976
6-87514358-C-A Likely benign (Jul 08, 2018)1196311
6-87514414-T-C Likely benign (Nov 25, 2023)800091
6-87514417-A-G Inborn genetic diseases Uncertain significance (Jan 26, 2022)2272835
6-87514425-T-TA not specified • Pontocerebellar hypoplasia type 6 Uncertain significance (Nov 11, 2013)215077
6-87514428-A-T Likely benign (May 21, 2022)1997671
6-87514432-G-A not specified Uncertain significance (Jan 03, 2022)1339743
6-87514437-T-G Likely benign (May 17, 2023)2118630
6-87514442-G-A Inborn genetic diseases • Pontocerebellar hypoplasia type 6 Uncertain significance (Jan 06, 2022)521519
6-87514446-T-C not specified • Congenital disorder of glycosylation • Pontoneocerebellar hypoplasia • Pontocerebellar hypoplasia type 6 Benign/Likely benign (Feb 01, 2024)130095
6-87514458-G-C Pontocerebellar hypoplasia type 6 Likely benign (Jun 04, 2023)747991
6-87514464-G-A Likely benign (Jun 20, 2023)2880435
6-87514471-C-A Uncertain significance (Jul 20, 2022)2136149
6-87514471-C-T Pontocerebellar hypoplasia type 6 Conflicting classifications of pathogenicity (Jun 26, 2024)215071
6-87514472-G-A Pontocerebellar hypoplasia type 6 Conflicting classifications of pathogenicity (Jan 22, 2024)766634
6-87514473-G-A Likely benign (Jun 14, 2023)1079161
6-87514475-C-T Pontocerebellar hypoplasia type 6 Uncertain significance (Aug 14, 2020)992187
6-87514476-A-G Likely benign (Apr 10, 2021)1549840
6-87514496-T-C Uncertain significance (Jun 10, 2021)1327908
6-87514501-T-C Pontocerebellar hypoplasia type 6 Pathogenic (Mar 14, 2024)3240275
6-87514507-A-G Likely benign (Apr 28, 2021)1124668

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RARS2protein_codingprotein_codingENST00000369536 2075626
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.74e-140.84412564501031257480.000410
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.06503083051.010.00001593780
Missense in Polyphen101118.720.850781392
Synonymous-0.7351151051.090.000005621068
Loss of Function1.952740.30.6690.00000204472

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009410.000941
Ashkenazi Jewish0.00009930.0000992
East Asian0.0006530.000653
Finnish0.00004620.0000462
European (Non-Finnish)0.0005020.000501
Middle Eastern0.0006530.000653
South Asian0.0003590.000359
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Disease
DISEASE: Pontocerebellar hypoplasia 6 (PCH6) [MIM:611523]: A disorder characterized by an abnormally small cerebellum and brainstem, infantile encephalopathy, generalized hypotonia, lethargy and poor feeding. Recurrent apnea, intractable seizures occur early in the course of this condition. {ECO:0000269|PubMed:17847012}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);tRNA Aminoacylation;Translation;Metabolism of proteins;tRNA charging;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Mitochondrial tRNA aminoacylation (Consensus)

Recessive Scores

pRec
0.123

Intolerance Scores

loftool
0.879
rvis_EVS
-0.13
rvis_percentile_EVS
43.91

Haploinsufficiency Scores

pHI
0.504
hipred
N
hipred_score
0.476
ghis
0.615

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.964

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rars2
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
rars2
Affected structure
midbrain hindbrain boundary
Phenotype tag
abnormal
Phenotype quality
dorso-ventrally flattened

Gene ontology

Biological process
tRNA aminoacylation for protein translation;arginyl-tRNA aminoacylation;mitochondrial translation
Cellular component
mitochondrion;mitochondrial matrix
Molecular function
RNA binding;arginine-tRNA ligase activity;ATP binding